Literature DB >> 19186126

Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability.

Anshuman Dixit1, Ali Torkamani, Nicholas J Schork, Gennady Verkhivker.   

Abstract

Structural and biochemical characterization of protein kinases that confer oncogene addiction and harbor a large number of disease-associated mutations, including RET and MET kinases, have provided insights into molecular mechanisms associated with the protein kinase activation in human cancer. In this article, structural modeling, molecular dynamics, and free energy simulations of a structurally conserved mutational hotspot, shared by M918T in RET and M1250T in MET kinases, are undertaken to quantify the molecular mechanism of activation and the functional role of cancer mutations in altering protein kinase structure, dynamics, and stability. The mechanistic basis of the activating RET and MET cancer mutations may be driven by an appreciable free energy destabilization of the inactive kinase state in the mutational forms. According to our results, the locally enhanced mobility of the cancer mutants and a higher conformational entropy are counterbalanced by a larger enthalpy loss and result in the decreased thermodynamic stability. The computed protein stability differences between the wild-type and cancer kinase mutants are consistent with circular dichroism spectroscopy and differential scanning calorimetry experiments. These results support the molecular mechanism of activation, which causes a detrimental imbalance in the dynamic equilibrium shifted toward the active form of the enzyme. Furthermore, computer simulations of the inhibitor binding with the oncogenic and drug-resistant RET mutations have also provided a plausible molecular rationale for the observed differences in the inhibition profiles, which is consistent with the experimental data. Finally, structural mapping of RET and MET cancer mutations and the computed protein stability changes suggest a similar mechanism of activation, whereby the cancer mutations which display the higher oncogenic activity tend to have the greatest destabilization effect on the inactive kinase structure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19186126      PMCID: PMC2716637          DOI: 10.1016/j.bpj.2008.10.041

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  106 in total

1.  Functional analysis of RET with Hirschsprung mutations affecting its kinase domain.

Authors:  T Iwashita; K Kurokawa; S Qiao; H Murakami; N Asai; K Kawai; M Hashimoto; T Watanabe; M Ichihara; M Takahashi
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations.

Authors:  Raphael Guerois; Jens Erik Nielsen; Luis Serrano
Journal:  J Mol Biol       Date:  2002-07-05       Impact factor: 5.469

3.  Evolutionary conservation of protein backbone flexibility.

Authors:  Sandra Maguid; Sebastián Fernández-Alberti; Gustavo Parisi; Julián Echave
Journal:  J Mol Evol       Date:  2006-10-04       Impact factor: 2.395

4.  Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase.

Authors:  Weiru Wang; Adhirai Marimuthu; James Tsai; Abhinav Kumar; Heike I Krupka; Chao Zhang; Ben Powell; Yoshihisa Suzuki; Hoa Nguyen; Maryam Tabrizizad; Catherine Luu; Brian L West
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

5.  Molecular evolution of affinity and flexibility in the immune system.

Authors:  Ian F Thorpe; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

6.  Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.

Authors:  N Nakaigawa; G Weirich; L Schmidt; B Zbar
Journal:  Oncogene       Date:  2000-06-15       Impact factor: 9.867

Review 7.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

8.  Structure and chemical inhibition of the RET tyrosine kinase domain.

Authors:  Phillip P Knowles; Judith Murray-Rust; Svend Kjaer; Rizaldy P Scott; Sarah Hanrahan; Massimo Santoro; Carlos F Ibáñez; Neil Q McDonald
Journal:  J Biol Chem       Date:  2006-08-23       Impact factor: 5.157

9.  Autophosphorylation dependent destabilization of the insulin receptor kinase domain: tryptophan-1175 reports changes in the catalytic cleft.

Authors:  S M Bishop; J B Ross; R A Kohanski
Journal:  Biochemistry       Date:  1999-03-09       Impact factor: 3.162

10.  CUPSAT: prediction of protein stability upon point mutations.

Authors:  Vijaya Parthiban; M Michael Gromiha; Dietmar Schomburg
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more
  21 in total

1.  Predicting folding free energy changes upon single point mutations.

Authors:  Zhe Zhang; Lin Wang; Yang Gao; Jie Zhang; Maxim Zhenirovskyy; Emil Alexov
Journal:  Bioinformatics       Date:  2012-01-11       Impact factor: 6.937

Review 2.  Annotating individual human genomes.

Authors:  Ali Torkamani; Ashley A Scott-Van Zeeland; Eric J Topol; Nicholas J Schork
Journal:  Genomics       Date:  2011-08-02       Impact factor: 5.736

3.  Mutations in penicillin-binding protein 2 from cephalosporin-resistant Neisseria gonorrhoeae hinder ceftriaxone acylation by restricting protein dynamics.

Authors:  Avinash Singh; Jonathan M Turner; Joshua Tomberg; Alena Fedarovich; Magnus Unemo; Robert A Nicholas; Christopher Davies
Journal:  J Biol Chem       Date:  2020-04-06       Impact factor: 5.157

4.  Rapid and accurate ranking of binding affinities of epidermal growth factor receptor sequences with selected lung cancer drugs.

Authors:  Shunzhou Wan; Peter V Coveney
Journal:  J R Soc Interface       Date:  2011-01-12       Impact factor: 4.118

5.  Structural assessment of the effects of amino acid substitutions on protein stability and protein protein interaction.

Authors:  Shaolei Teng; Anand K Srivastava; Charles E Schwartz; Emil Alexov; Liangjiang Wang
Journal:  Int J Comput Biol Drug Des       Date:  2011-02-04

Review 6.  Computational algorithms for in silico profiling of activating mutations in cancer.

Authors:  E Joseph Jordan; Keshav Patil; Krishna Suresh; Jin H Park; Yael P Mosse; Mark A Lemmon; Ravi Radhakrishnan
Journal:  Cell Mol Life Sci       Date:  2019-04-13       Impact factor: 9.261

Review 7.  Kinase mutations in human disease: interpreting genotype-phenotype relationships.

Authors:  Piya Lahiry; Ali Torkamani; Nicholas J Schork; Robert A Hegele
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

Review 8.  Hereditary breast and ovarian cancer: new genes in confined pathways.

Authors:  Finn Cilius Nielsen; Thomas van Overeem Hansen; Claus Storgaard Sørensen
Journal:  Nat Rev Cancer       Date:  2016-08-12       Impact factor: 60.716

9.  Sequence and structure signatures of cancer mutation hotspots in protein kinases.

Authors:  Anshuman Dixit; Lin Yi; Ragul Gowthaman; Ali Torkamani; Nicholas J Schork; Gennady M Verkhivker
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

10.  Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.

Authors:  Anshuman Dixit; Gennady M Verkhivker
Journal:  PLoS Comput Biol       Date:  2009-08-28       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.